Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The study is testing the hypothesis, that the application of low dose erythropoetin beta (35 I.E./kg BW/week) for 6 months following successful coronary revascularization by PCI improves left ventricular remodeling as assessed by cardiac MRI.
Epistemonikos ID: 7fb194d6f0653b8933b84fbea5d623d0cecd2d0c
First added on: May 04, 2024